MAZE — Maze Therapeutics

Median target
$55.5
calls from the last 12 months
Implied return
+72.1%
median target vs. price
Coverage
11 analysts · 12 calls
updated in the last 12 months
Consensus
11/0/0+11 net
Buy / Hold / Sell

Which analysts are behind MAZE's consensus?

See every current rating, price target and the analysts' track records for Maze Therapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 11 analysts with calls on MAZE updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

MAZE elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-11-02InsidersColoma Jason VChief Executive OfficerInsider sale26.6K sh @ $30.09 · planned trade$799K
2026-11-02InsidersColoma Jason VChief Executive OfficerInsider sale5.3K sh @ $31.05 · planned trade$166K
2026-11-02InsidersColoma Jason VChief Executive OfficerInsider sale2.3K sh @ $30.12 · planned trade$68K
2026-11-02InsidersColoma Jason VChief Executive OfficerInsider sale336 sh @ $30.91 · planned trade$10K
2026-10-29InsidersDandekar AtulCSBOInsider sale7.5K sh @ $32.07 · planned trade$241K
2026-10-01InsidersColoma Jason VChief Executive OfficerInsider sale31.9K sh @ $27.02 · planned trade$862K
2026-10-01InsidersBernstein HaroldPresident, R&D & CMOInsider sale16.1K sh @ $26.93 · planned trade$435K
2026-10-01InsidersColoma Jason VChief Executive OfficerInsider sale2.6K sh @ $27.02 · planned trade$70K
2026-09-29InsidersDandekar AtulCSBOInsider sale7.5K sh @ $27.06 · planned trade$203K

More: insider activity · executive branch · trending